Associate Professor, Medicine, Northwestern University Medical School
Gastroenterology
Dr. Josh Levitsky, MD
|
|
Give Review
Josh Levitsky is an expert in the field of Gastroenterology. He attended University of Nebraska Medical Center. University of Nebraska Medical Center is a top medical university. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care Josh Levitsky, MD is a published doctor as well. He has 63 publications published. The latest was: Low Incidence of Acute Rejection in Hepatitis B Virus Positive Liver Transplant Recipients and the Impact of Hepatitis B Immunoglobulin. Josh Levitsky is registered with Medicare and accepts Medicare payments.
Publications
- Low Incidence of Acute Rejection in Hepatitis B Virus Positive Liver Transplant Recipients and the Impact of Hepatitis B Immunoglobulin.
- Management of the Critically Ill Patient with Cirrhosis: A Multidisciplinary Perspective.
- Incidence and impact of rejection following simultaneous liver-kidney transplantation.
- Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.
- Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies.
- The impact of coronary artery Disease on outcomes after liver transplantation.
- An Interferon-free Antiviral Regimen for HCV after Liver Transplantation.
- A meta-analysis of complications following deceased donor liver transplant.
- Medication misuse, non-adherence, and clinical outcomes among liver transplant recipients.
- The current state and future prospects of chronic Hepatitis C virus infection treatment.
- Comparative Effectiveness of Liver Transplant Strategies for End-Stage Liver Disease Patients on Renal Replacement Therapy.
- Hepatotoxicity and drug interactions in liver transplant candidates and recipients.
- Genomic Biomarkers Correlate with HLA-Identical Renal Transplant Tolerance.
- Find it in your heart.
- A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus.
- Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients.
- Meeting report of the International Liver Transplantation Society's 18th annual international congress: Hilton San Francisco Hotel, San Francisco, CA, May 16-19, 2012.
- Outcomes and native renal recovery following simultaneous liver-kidney transplantation.
- Crohn's Disease and Takayasu's arteritis.
- Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation.
- Varicella infection following varicella vaccination in a liver transplant recipient.
- The safety and outcome of joint replacement surgery in liver transplant recipients.
- Oral vitamin a therapy for a patient with a severely symptomatic postradiation anal Ulceration: report of a case.
- The effect of immunosuppressive regimens on the recurrence of primary Biliary cirrhosis after liver transplantation.
- American Association for the Study of Liver Diseases--53rd Annual Meeting. 1-5 November 2002, Boston, MA, USA.
- Diagnosis and therapy of alcoholic liver Disease.
- A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy.
- Herpes zoster infection after liver transplantation: a case-control study.
- Fulminant liver failure associated with the use of black cohosh.
- Operative risk of total hip and knee arthroplasty in cirrhotic patients.
- Chicken pox after pediatric liver transplantation.
- Meta-analysis: the efficacy of strategies to prevent organ Disease by cytomegalovirus in solid organ transplant recipients.
- The liver transplant recipient: what you need to know for long-term care.
- Probiotics: application of "healthy" bacteria to liver transplant recipients.
- Acid-base and potassium disorders in liver Disease.
- Hepatic complications of hematopoietic cell transplantation.
- Herpes simplex virus Hepatitis: an analysis of the published literature and institutional cases.
- Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes?
- Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure.
- Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents.
- Transjugular intrahepatic portoSystemic shunt with thrombectomy for the treatment of portal vein thrombosis after liver transplantation.
- Evaluation of the coagulation and inflammatory Responses in solid organ transplant recipients and donors.
- Outcomes of patients with Hepatitis C undergoing simultaneous liver-kidney transplantation.
- Overview of immunosuppression in liver transplantation.
- The human "Treg MLR": Immune monitoring for FOXP3+ T regulatory cell generation.
- Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection.
- The renal benefit of mycophenolate mofetil after liver transplantation.
- Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction.
- Meeting report of the 16th Annual International Congress of the International Liver Transplantation Society.
- Alemtuzumab induction in non-Hepatitis C positive liver transplant recipients.
- Glycemic control by a glucose management service and infection rates after liver transplantation.
- Assessment of chronic Hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging.
- Operational tolerance: past lessons and future prospects.
- Association of hepatic artery stenosis and Biliary strictures in liver transplant recipients.
- Next level of immunosuppression: drug/Immune monitoring.
- Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.
- Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent Hepatitis C in liver transplant recipients.
- Chronic rejection related to Hepatitis B immunoglobulin discontinuation in a liver transplant recipient.
- Haploidentical hematopoietic stem cell transplantation for graft-versus-host Disease after liver transplantation.
- Mycophenolate mofetil monotherapy in liver transplant recipients.
- Meeting report of the 2011 joint international congress of ILTS, ELITA, & LICAGE valencia congress centre, valencia, SPain, June 22-25, 2011.
- Favorable effects of alemtuzumab on allospecific regulatory T-cell generation.
Schools
Albert Einstein College of Medicine of Yeshiva University
University Of Chicago Hosps
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- HealthLink PPO
- Choice Care PPO
- MedHealthInsurance
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Principal Life
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Education
-
University of Nebraska Medical Center -
University of Chicago -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1770573305 | |
| NPPES Provider LastName | LEVITSKY | |
| NPPES Provider FirstName | JOSH | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 1776.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770573305 |
| Last Name Of The Provider | LEVITSKY |
| First Name Of The Provider | JOSH |
| View All |
Similar Doctors
|
|
Dr. Michael O. Blackstone, MD |
|
Dr. Subramanian Venkataraman, MD |
|
|
Dr. Laura Yun, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Gawron, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amritbhai Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan P. Gaspar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin R. Fintel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sukanya Subramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carline Quander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila L. Eswaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Martin, MD |
|
|
Dr. Ayokunle T. Abegunde, MD
This Doctor is OpenDoctor Recommended.
|